Acute Rheumatic Fever and Rheumatic Heart Disease in Children Aged Less Than 5 Years in the Northern Territory Between 2010 and 2020

2010年至2020年北领地5岁以下儿童急性风湿热和风湿性心脏病病例

阅读:1

Abstract

AIM: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are preventable diseases affecting socioeconomically disadvantaged populations globally, including Australian children. This study aims to describe the clinical presentation and outcomes of ARF and RHD in children aged less than 5 years, to improve recognition and management. METHOD: A retrospective audit was undertaken of children aged less than 5 years with ARF and RHD in the Northern Territory (NT) of Australia between 2010 and 2020. Patients were identified from the NT RHD register. Descriptive data analyses were performed to summarise patient demographics, clinical presentation, diagnosis, disease severity, management, and outcomes. RESULTS: During the study period, 82 children (51% female) aged less than 5 years presented with definite, probable, or possible ARF (78/82), and/or RHD (20/82). Aboriginal and Torres Strait Islander children were disproportionately affected, with average annual incidences (2010-2020) of ARF and RHD of 127 (95% confidence interval [CI]: 99-155) and 33 (95% CI: 18-47) per 100,000 population, respectively. ARF recurrence was common (23%). At diagnosis, RHD was moderate to severe in 55% of cases, and 20% of children with RHD required one or more cardiac surgeries. CONCLUSION: Children aged less than 5 years living in remote NT are at risk of ARF and RHD. Aboriginal and Torres Strait Islander children are disproportionately affected. Presentations with sore joints, chorea, new cardiac murmurs or other symptoms suggestive of ARF should be fully investigated. Echocardiographic screening for RHD should be considered for children living in remote NT from the age of 3 years.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。